Central Alerting System
View Alert

Originator: National Patient Safety Alert - MHRA

Issue date: 27-Jun-2023 12:36:12

This alert has been issued to:
  • Care Trusts
  • Mental Health Trusts
  • Specialists Trusts
  • Learning Disabilities Trusts
  • Mental Health & Social Care Trusts
  • Ambulance Trusts
  • Mental Health & Learning Disabilities Trusts
  • Acute Trusts
  • Community Trusts

  • Other contacts
  • Independent Healthcare Providers (registered with CAS)
  • Clinical Commissioning Groups
  • Special Health Authorities
  • Territorial CMOs in Northern Ireland, Scotland & Wales

Action category: Action

Title: Potential risk of underdosing with calcium gluconate in severe hyperkalaemia

Broadcast content: This alert highlights the Adult Renal Association Clinical Practice Guidelines (2020) recommendation on calcium gluconate use to support organisations to update local policies and guidelines for the treatment of severe hyperkalaemia in adults. The MHRA has also published a Drug Safety Update article with further information.

This National Patient Safety Alert provides further background and clinical information and actions for providers.

Additional information: This alert is not relevant to primary care.

Alert reference: NatPSA/2023/007/MHRA

Action underway deadline: 29-Jun-2023

Action complete deadline: 01-Dec-2023


Contact our helpdesk

Email: safetyalerts@mhra.gov.uk

Medicines and Healthcare products Regulatory Agency